| Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer (NCT02865135) | Dana-Farber Cancer Institute | 2017-03-30 |
| Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis (NCT02745184) | Shanghai East Hospital | 2017-03-30 |
| Exploring the Role of the GABAergic Modulation in Pain Transmission in Human (NCT03375034) | Jules Desmeules | 2017-03-30 |
| Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease (NCT02970019) | Sun Pharma Advanced Research Company Limited | 2017-03-30 |
| Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections (NCT03038971) | Woodmont Pharmaceuticals, Inc. | 2017-03-30 |
| A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies (NCT03106428) | MedImmune LLC | 2017-03-29 |
| Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer (NCT02963610) | Fox Chase Cancer Center | 2017-03-29 |
| Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea (NCT03050086) | BioPharmX, Inc. | 2017-03-29 |
| Human Mass Balance Study of HMS5552 in Healthy Subjects (NCT03158506) | Hua Medicine Limited | 2017-03-29 |
| Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59 (NCT03144999) | Janssen Research & Development, LLC | 2017-03-29 |
| A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects (NCT03061981) | Dong-A ST Co., Ltd. | 2017-03-29 |
| Treatment Development of Triheptanoin (G1D) (NCT03041363) | Juan Pascual | 2017-03-29 |
| Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BGB-3111 in Healthy Males (NCT04163783) | BeiGene | 2017-03-29 |
| Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial (NCT03066258) | REGENXBIO Inc. | 2017-03-29 |
| A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer (NCT03081819) | Kyunghee University Medical Center | 2017-03-29 |
| A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects. (NCT03128606) | Lakefront Biotherapeutics NV | 2017-03-28 |
| Imaging the Neuroimmune System in PTSD (NCT04236986) | Yale University | 2017-03-28 |
| Clinical Study of Decitabine and Paclitaxel Combination Therapy (NCT03282825) | Dong Wha Pharmaceutical Co. Ltd. | 2017-03-28 |
| A Study to Investigate the Potential Influence of Nitisinone on the Metabolism and the Transport of Other Drugs in Healthy Volunteers (NCT03103568) | Swedish Orphan Biovitrum | 2017-03-28 |
| A Study to Evaluate ACT-132577 in Healthy Male Subjects (NCT03100591) | Idorsia Pharmaceuticals Ltd. | 2017-03-28 |
| A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of Administration (NCT03084289) | University of Oxford | 2017-03-28 |
| The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers (NCT03693950) | Biocad | 2017-03-28 |
| Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan) (NCT03092999) | Bayer | 2017-03-28 |
| Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women (NCT03103646) | H. Lundbeck A/S | 2017-03-28 |
| A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood (NCT03082183) | Boehringer Ingelheim | 2017-03-28 |
| Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil (NCT03240939) | Yuyu Pharma, Inc. | 2017-03-27 |
| Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCL (NCT03259529) | St. Petersburg State Pavlov Medical University | 2017-03-27 |
| A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4) (NCT03111511) | Janssen Sciences Ireland UC | 2017-03-27 |
| Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers. (NCT03023397) | University of North Carolina, Chapel Hill | 2017-03-27 |
| APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors (NCT03053466) | Apollomics (Australia) Pty. Ltd. | 2017-03-27 |
| A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy Participants (NCT03083639) | Takeda | 2017-03-27 |
| Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma (NCT02989870) | H. Lee Moffitt Cancer Center and Research Institute | 2017-03-27 |
| Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer (NCT02946008) | University of Michigan Rogel Cancer Center | 2017-03-27 |
| A Single Ascending Dose Study of Safety and Tolerability of STA363 Compared to Placebo in 15 Patients With Chronic Discogenic Low Back Pain (NCT03055845) | Stayble Therapeutics | 2017-03-27 |
| Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma (NCT03059147) | SignalRX Pharmaceuticals, Inc. | 2017-03-27 |
| Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients (NCT03028103) | Epizyme, Inc. | 2017-03-27 |
| Derma-Stent Novel Abscess Packing Device (NCT03171714) | Aaron Brody, MD, MPH | 2017-03-27 |
| Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne (NCT03076320) | University of Guadalajara | 2017-03-27 |
| Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and Lamivudine (NCT03078556) | ViiV Healthcare | 2017-03-27 |
| A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults (NCT02990325) | Abivax S.A. | 2017-03-27 |
| A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis (NCT03089229) | Haus Bioceuticals | 2017-03-26 |
| Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects (NCT03202927) | Adello Biologics, LLC | 2017-03-25 |
| Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT (NCT03114670) | Affiliated Hospital to Academy of Military Medical Sciences | 2017-03-25 |
| Manipulating the Gut Microbiome Study (NCT03181828) | Nicholas Ah Mew | 2017-03-24 |
| Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects (NCT03193203) | Samsung Bioepis Co., Ltd. | 2017-03-24 |
| A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402 (NCT02897726) | NVP Healthcare | 2017-03-24 |
| Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA (NCT03033680) | Brigham and Women's Hospital | 2017-03-24 |
| A Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor Positron Emission Tomography (PET) Tracer 18F-JNJ-64413739 (NCT03088644) | Janssen-Cilag International NV | 2017-03-24 |
| A Study of HTD1801 in Healthy Subjects (NCT03099603) | HighTide Therapeutics (Hong Kong) Limited | 2017-03-24 |
| A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations (NCT03082300) | Astellas Pharma Global Development, Inc. | 2017-03-24 |
| A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers (NCT02891980) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-24 |
| Functional Connectivity as a Biomarker of rTMS (NCT03050801) | National Institute of Neurological Disorders and Stroke (NINDS) | 2017-03-24 |
| Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer (NCT03096340) | Intezyne Technologies, Inc. | 2017-03-23 |
| Flortaucipir 18F PET Imaging in BIOCARD Study (NCT03052972) | Avid Radiopharmaceuticals | 2017-03-23 |
| Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer (NCT02503722) | National Cancer Institute (NCI) | 2017-03-23 |
| Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD) (NCT03282929) | Bausch & Lomb Incorporated | 2017-03-23 |
| Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer (NCT02996825) | City of Hope Medical Center | 2017-03-22 |
| Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC (NCT03136627) | AVEO Pharmaceuticals, Inc. | 2017-03-22 |
| A Study of AV0328 Administered to Healthy Adult Volunteers (NCT02853617) | Alopexx Vaccine, LLC | 2017-03-22 |
| The Effect of Cryotherapy on Cerebral Hemodynamics Within Healthy Subjects (NCT03185507) | University of Virginia | 2017-03-22 |
| Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia (NCT03103009) | University of Colorado, Denver | 2017-03-22 |
| Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study) (NCT02707042) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-22 |
| Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study (NCT03000283) | Jesse Corry | 2017-03-22 |
| Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery (NCT02700230) | Mayo Clinic | 2017-03-22 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) in Healthy Japanese Participants (NCT03040635) | Hoffmann-La Roche | 2017-03-22 |
| A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT03071757) | AbbVie | 2017-03-21 |
| Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin (NCT03043989) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-21 |
| Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System (NCT03067051) | SpectraCure AB | 2017-03-21 |
| Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors (NCT03101488) | 3D Medicines (Sichuan) Co., Ltd. | 2017-03-21 |
| NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLC (NCT03029273) | Guangzhou Institute of Respiratory Disease | 2017-03-21 |
| MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel. (NCT03089645) | MedImmune LLC | 2017-03-21 |
| Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants (NCT03076970) | Eli Lilly and Company | 2017-03-21 |
| Bioequivalence of Tablet Formulation of Dabigatran Etexilate Compared to Commercial Capsule Formulation Following Oral Administration in Healthy Male Subjects (NCT03070171) | Boehringer Ingelheim | 2017-03-21 |
| HDCRT Plus Pembrolizumab in Advanced Malignancies (NCT02987166) | James Larner, MD | 2017-03-21 |
| Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area (NCT03008122) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-21 |
| Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations (NCT03087786) | Niconovum USA | 2017-03-21 |
| Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity (NCT03095807) | Novo Nordisk A/S | 2017-03-20 |
| A MAD Study of TT301/MW189 in Healthy Volunteers (NCT02942771) | Linda Van Eldik | 2017-03-20 |
| Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia (NCT02782403) | M.D. Anderson Cancer Center | 2017-03-20 |
| A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies (NCT03082209) | AbbVie | 2017-03-20 |
| Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC) (NCT03063762) | Hoffmann-La Roche | 2017-03-20 |
| Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies (NCT02985554) | University of Chicago | 2017-03-20 |
| Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders (NCT03128996) | Washington University School of Medicine | 2017-03-20 |
| Study of AMV564 in Patients With AML (NCT03144245) | Amphivena Therapeutics, Inc. | 2017-03-20 |
| A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% (NCT03257943) | Sun Pharmaceutical Industries, Inc. | 2017-03-20 |
| The Effect of Ixazomib on the Latent HIV Reservoir (NCT02946047) | Mayo Clinic | 2017-03-20 |
| Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults (NCT03046550) | Alachua Government Services, Inc. | 2017-03-20 |
| Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients (NCT02912793) | Cyclo Therapeutics, Inc. | 2017-03-20 |
| A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit. (NCT03130179) | McNeil AB | 2017-03-20 |
| Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients (NCT03019003) | Massachusetts General Hospital | 2017-03-20 |
| Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy Volunteers (NCT03516630) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2017-03-20 |
| Daratumumab for the Treatment of Patients With AL Amyloidosis (NCT02841033) | Boston Medical Center | 2017-03-20 |
| Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets (NCT03100838) | Food and Drug Administration (FDA) | 2017-03-20 |
| JSP191 Antibody Targeting Conditioning in SCID Patients (NCT02963064) | Jasper Therapeutics, Inc. | 2017-03-20 |
| A Study of NKTR-358 (LY3471851) in Healthy Participants (NCT04380324) | Nektar Therapeutics | 2017-03-19 |
| A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL (NCT03060850) | Hangzhou ACEA Pharmaceutical Research Co., Ltd. | 2017-03-17 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas (NCT03049449) | National Cancer Institute (NCI) | 2017-03-17 |
| Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2 (NCT03129828) | Prof. Dr. Clemens Schmitt | 2017-03-17 |
| Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment (NCT03114540) | Pfizer | 2017-03-17 |